Medicines for Europe responds to call for increased access

Medicines for Europe, a group representing the European generic and biosimilar industries, has responded to a recent European Council declaration on good healthcare access, stating the industry is “ready to engage with the EU” to improve access to medicines.

The lobby group noted that the industry supplies “close to 70% of prescription medicines,” for European patients.

The group added: “Generic medicines have doubled access to therapy in major chronic diseases over the last 10 years and biosimilar medicines offer a similar hope for patients requiring biological medicines.”